Risk Prediction Model for Early Hodgkin's Lymphoma Outperforms Widely Used Standard

(MedPage Today) — A prognostication tool for early classic Hodgkin’s lymphoma (cHL) outperformed a widely used classification system in predicting 2-year progression-free survival (PFS), according to training and validation studies involving more…

Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/116247

Author :

Publish date : 2025-06-25 19:03:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Risk Prediction Model for Early Hodgkin’s Lymphoma Outperforms Widely Used Standard

Gastric bypass surgery may cut the risk of bowel cancer

New and Improved Navitor Makes for a Serious TAVR Contender

Related Posts

CDC Experts Make the Case for Maternal COVID Vaccination

HHS Hunts for New Autism Links While David Geier Searches for ‘Lost’ Vaccine Data

CDC Director Nominee Faces Tough Questions at Senate Hearing

FDA Requires Updated Warning About Rare Heart Risk With COVID Shots

Motor Function, Cardiac Outcomes Improve With Gene Therapy in Pompe’s Disease

RFK Jr.’s Vaccine Panel to Study Childhood Immunization Schedule